Schrödinger Taps Google Cloud HPC Solution to Bolster Drug Discovery

Schridinger has entered into a three-year agreement with Google Cloud to substantially increase the speed and capacity of its physics-based computational platform for drug discovery. "We're excited to harness Google Cloud's highly scalable system to run extensive free energy calculations to assess binding affinities through our compute-intensive FEP+ application. This partnership also enables us to further leverage BigQuery to analyze important molecular properties nearly instantaneously," said Shane Brauner, Schridinger's Chief Information Officer. "This partnership is expected to allow us to expand the use of our physics-based computational platform to continue to rapidly explore very large swaths of chemical space."

The post Schridinger Taps Google Cloud HPC Solution to Bolster Drug Discovery appeared first on insideHPC.